These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12610048)

  • 21. Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality.
    Onat A; Can G; Kaya A; Akbaş T; Özpamuk-Karadeniz F; Şimşek B; Çakır H; Yüksel H
    World J Gastroenterol; 2015 Dec; 21(48):13555-65. PubMed ID: 26730168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.
    Kuller LH; Velentgas P; Barzilay J; Beauchamp NJ; O'Leary DH; Savage PJ
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):823-9. PubMed ID: 10712409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular disease incidence, mortality and case fatality related to diabetes and metabolic syndrome: A community-based prospective study (Ansung-Ansan cohort 2001-12).
    Bae JC; Cho NH; Suh S; Kim JH; Hur KY; Jin SM; Lee MK
    J Diabetes; 2015 Nov; 7(6):791-9. PubMed ID: 25407754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
    Daniels LB; Grady D; Mosca L; Collins P; Mitlak BH; Amewou-Atisso MG; Wenger NK; Barrett-Connor E;
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):164-70. PubMed ID: 23481531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular shape predicts different types of cardiovascular events in the general population.
    Ambale-Venkatesh B; Yoneyama K; Sharma RK; Ohyama Y; Wu CO; Burke GL; Shea S; Gomes AS; Young AA; Bluemke DA; Lima JA
    Heart; 2017 Apr; 103(7):499-507. PubMed ID: 27694110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001.
    Kronmal RA; Barzilay JI; Smith NL; Psaty BM; Kuller LH; Burke GL; Furberg C
    PLoS Med; 2006 Oct; 3(10):e400. PubMed ID: 17048978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease.
    Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL
    Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Artery Calcium Volume and Density: Potential Interactions and Overall Predictive Value: The Multi-Ethnic Study of Atherosclerosis.
    Criqui MH; Knox JB; Denenberg JO; Forbang NI; McClelland RL; Novotny TE; Sandfort V; Waalen J; Blaha MJ; Allison MA
    JACC Cardiovasc Imaging; 2017 Aug; 10(8):845-854. PubMed ID: 28797404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population.
    Hadaegh F; Hatami M; Mohebi R; Hasheminia M; Bozorgmanesh M; Sheikholeslami F; Azizi F
    Eur J Prev Cardiol; 2012 Dec; 19(6):1227-33. PubMed ID: 22013153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial.
    Eberly LE; Prineas R; Cohen JD; Vazquez G; Zhi X; Neaton JD; Kuller LH;
    Diabetes Care; 2006 Jan; 29(1):123-30. PubMed ID: 16373907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different glucose tolerance status and incident cardiovascular disease and all-cause mortality among elderly Iranians.
    Mirbolouk M; Hajebrahimi MA; Akbarpour S; Tohidi M; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2016 Dec; 16(12):1263-1271. PubMed ID: 26463623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.
    Hadaegh F; Derakhshan A; Mozaffary A; Hasheminia M; Khalili D; Azizi F
    PLoS One; 2016; 11(3):e0149780. PubMed ID: 26930192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program.
    Rodriguez BL; Lau N; Burchfiel CM; Abbott RD; Sharp DS; Yano K; Curb JD
    Diabetes Care; 1999 Aug; 22(8):1262-5. PubMed ID: 10480768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in risk factors for coronary heart disease among diabetic and nondiabetic individuals from a population with high rates of diabetes: the Strong Heart Study.
    Xu J; Lee ET; Peterson LE; Devereux RB; Rhoades ER; Umans JG; Best LG; Howard WJ; Paranilam J; Howard BV
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3766-74. PubMed ID: 22802089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of CAC Score and Risk of Incident CVD.
    Radford NB; DeFina LF; Barlow CE; Lakoski SG; Leonard D; Paixao AR; Khera A; Levine BD
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1420-1429. PubMed ID: 27372023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: An overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN).
    Hirakawa Y; Ninomiya T; Kiyohara Y; Murakami Y; Saitoh S; Nakagawa H; Okayama A; Tamakoshi A; Sakata K; Miura K; Ueshima H; Okamura T;
    J Epidemiol; 2017 Mar; 27(3):123-129. PubMed ID: 28142033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    Son JS; Choi S; Kim K; Kim SM; Choi D; Lee G; Jeong SM; Park SY; Kim YY; Yun JM; Park SM
    JAMA; 2018 Nov; 320(17):1783-1792. PubMed ID: 30398603
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.